Literature DB >> 25641834

Engineered bromodomains to explore the acetylproteome.

Bryan D Bryson1, Amanda M Del Rosario, Jonathan S Gootenberg, Michael B Yaffe, Forest M White.   

Abstract

MS-based analysis of the acetylproteome has highlighted a role for acetylation in a wide array of biological processes including gene regulation, metabolism, and cellular signaling. To date, anti-acetyllysine antibodies have been used as the predominant affinity reagent for enrichment of acetyllysine-containing peptides and proteins; however, these reagents suffer from high nonspecific binding and lot-to-lot variability. Bromodomains represent potential affinity reagents for acetylated proteins and peptides, given their natural role in recognition of acetylated sequence motifs in vivo. To evaluate their efficacy, we generated recombinant proteins representing all known yeast bromodomains. Bromodomain specificity for acetylated peptides was determined using degenerate peptide arrays, leading to the observation that different bromodomains display a wide array of binding specificities. Despite their relatively weak affinity, we demonstrate the ability of selected bromodomains to enrich acetylated peptides from a complex biological mixture prior to mass spectrometric analysis. Finally, we demonstrate a method for improving the utility of bromodomain enrichment for MS through engineering novel affinity reagents using combinatorial tandem bromodomain pairs.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Affinity reagent; Bromodomain; Lysine acetylation; Posttranslational modification; Protein engineering; Technology

Mesh:

Substances:

Year:  2015        PMID: 25641834      PMCID: PMC4535431          DOI: 10.1002/pmic.201400401

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  18 in total

1.  Structure and function of a human TAFII250 double bromodomain module.

Authors:  R H Jacobson; A G Ladurner; D S King; R Tjian
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

2.  SH2 domains recognize contextual peptide sequence information to determine selectivity.

Authors:  Bernard A Liu; Karl Jablonowski; Eshana E Shah; Brett W Engelmann; Richard B Jones; Piers D Nash
Journal:  Mol Cell Proteomics       Date:  2010-07-13       Impact factor: 5.911

3.  Substrate and functional diversity of lysine acetylation revealed by a proteomics survey.

Authors:  Sung Chan Kim; Robert Sprung; Yue Chen; Yingda Xu; Haydn Ball; Jimin Pei; Tzuling Cheng; Yoonjung Kho; Hao Xiao; Lin Xiao; Nick V Grishin; Michael White; Xiang-Jiao Yang; Yingming Zhao
Journal:  Mol Cell       Date:  2006-08       Impact factor: 17.970

4.  High-throughput phosphotyrosine profiling using SH2 domains.

Authors:  Kazuya Machida; Christopher M Thompson; Kevin Dierck; Karl Jablonowski; Satu Kärkkäinen; Bernard Liu; Haimin Zhang; Piers D Nash; Debra K Newman; Peter Nollau; Tony Pawson; G Herma Renkema; Kalle Saksela; Martin R Schiller; Dong-Guk Shin; Bruce J Mayer
Journal:  Mol Cell       Date:  2007-06-22       Impact factor: 17.970

5.  A biotin switch-based proteomics approach identifies 14-3-3ζ as a target of Sirt1 in the metabolic regulation of caspase-2.

Authors:  Joshua L Andersen; J Will Thompson; Kelly R Lindblom; Erika S Johnson; Chih-Sheng Yang; Lauren R Lilley; Christopher D Freel; M Arthur Moseley; Sally Kornbluth
Journal:  Mol Cell       Date:  2011-09-02       Impact factor: 17.970

6.  DNA damage activates p53 through a phosphorylation-acetylation cascade.

Authors:  K Sakaguchi; J E Herrera; S Saito; T Miki; M Bustin; A Vassilev; C W Anderson; E Appella
Journal:  Genes Dev       Date:  1998-09-15       Impact factor: 11.361

7.  Structure and ligand of a histone acetyltransferase bromodomain.

Authors:  C Dhalluin; J E Carlson; L Zeng; C He; A K Aggarwal; M M Zhou
Journal:  Nature       Date:  1999-06-03       Impact factor: 49.962

8.  The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain.

Authors:  Andrew E H Elia; Peter Rellos; Lesley F Haire; Jerry W Chao; Frank J Ivins; Katja Hoepker; Duaa Mohammad; Lewis C Cantley; Stephen J Smerdon; Michael B Yaffe
Journal:  Cell       Date:  2003-10-03       Impact factor: 41.582

9.  Lysine acetylation is a highly abundant and evolutionarily conserved modification in Escherichia coli.

Authors:  Junmei Zhang; Robert Sprung; Jimin Pei; Xiaohong Tan; Sungchan Kim; Heng Zhu; Chuan-Fa Liu; Nick V Grishin; Yingming Zhao
Journal:  Mol Cell Proteomics       Date:  2008-08-23       Impact factor: 5.911

10.  Identification of lysine 37 of histone H2B as a novel site of methylation.

Authors:  Kathryn E Gardner; Li Zhou; Michael A Parra; Xian Chen; Brian D Strahl
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

View more
  6 in total

Review 1.  Proteins and Proteoforms: New Separation Challenges.

Authors:  Fred E Regnier; JinHee Kim
Journal:  Anal Chem       Date:  2017-12-18       Impact factor: 6.986

2.  Engineered Reader Proteins for Enhanced Detection of Methylated Lysine on Histones.

Authors:  Katherine I Albanese; Mackenzie W Krone; Christopher J Petell; Madison M Parker; Brian D Strahl; Eric M Brustad; Marcey L Waters
Journal:  ACS Chem Biol       Date:  2019-11-01       Impact factor: 5.100

Review 3.  Emerging Proteomic Technologies Provide Enormous and Underutilized Potential for Brain Cancer Research.

Authors:  Qiang Tian; Vineet Sangar; Nathan D Price
Journal:  Mol Cell Proteomics       Date:  2015-09-25       Impact factor: 5.911

4.  Bromodomains shake the hegemony of pan-acetyl antibodies.

Authors:  Morgane Champleboux; Jérôme Govin
Journal:  Proteomics       Date:  2015-05       Impact factor: 3.984

Review 5.  Building a KATalogue of acetyllysine targeting and function.

Authors:  Michael Downey; Kristin Baetz
Journal:  Brief Funct Genomics       Date:  2015-10-27       Impact factor: 4.241

6.  SPOTing Acetyl-Lysine Dependent Interactions.

Authors:  Sarah Picaud; Panagis Filippakopoulos
Journal:  Microarrays (Basel)       Date:  2015-08-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.